Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
olanzapine, Quantity: 10 mg
Medis Pharma Pty Ltd
Olanzapine
Tablet, orally disintegrating
Excipient Ingredients: microcrystalline cellulose; mannitol; pregelatinised maize starch; crospovidone; sodium lauryl sulfate; aspartame; colloidal anhydrous silica; magnesium stearate; Guar Gum
Oral
28 tablet
(S4) Prescription Only Medicine
Treatment of schizophrenia and related psychoses. Short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar I disorder. Preventing recurrence of manic, mixed or depressive episodes in bipolar I disorder.
Visual Identification: Yellow coloured, round shaped tablets, convex on one side and flat on the other; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2011-02-17